Ann Surg 1996, 224:131–138 PubMedCrossRef 27 Sauerland S, Agrest

Ann Surg 1996, 224:131–138.PubMedCrossRef 27. Sauerland S, Agresta F, Bergamaschi R: Laparoscopy for abdominal emergencies. Surg Endosc 2006, 20:14–29.PubMedCrossRef 28. Bertleff MJ, Halm JA, Bemelman WA, van der Ham AC: Randomized clinical trial of laparoscopic versus

open repair of the perforated peptic ulcer: the LAMA Trial. World J Surg 2009, 33:1368–1373.PubMedCrossRef 29. Lunevicius R, Morkevicius M: Risk factors influencing the early outcome results after laparoscopic repair of perforated duodenal ulcer and their predictive value. Langenbecks Arch Surg 2005, 390:413–420.PubMedCrossRef 30. Kirshtein B, Bayme M, Mayer T: Laparoscopic treatment of gastroduodenal perforations. Surg Endosc 2005, 19:1487–1490.PubMedCrossRef 31. Kohler L: Endoscopic surgery: what has passed the test? www.selleckchem.com/products/oligomycin-a.html World J Surg 1999, 23:816–824.PubMedCrossRef 32. Bertleff MJOE, Liem RSB, PLX-4720 cell line Bartels HL: The Stamp method: a new treatment for perforated peptic ulcer? Surg Endosc 2006, 20:791–793.PubMedCrossRef 33. Schein M, Gecelter G, Freinkel W: Peritoneal lavage in abdominal

sepsis. A controlled clinical study. Arch Surg 1990, 125:1132–1135.PubMedCrossRef 34. Svanes C: Trends in perforated peptic ulcer: incidence, etiology, treatment, and prognosis. World J Surg 2000, 24:277–283.PubMedCrossRef Competing interests The authors have declared that no competing interests.”
“Ferdinando Agresta Italy Ali Aminian Iran Darius Deo Balumuka Tanzania Sandro Barni Italy Jasneet Bhullar United States of America Walter Biffl United States of America Saptarshi Biswas United States of America L.D. Britt United States of America Desiree Burger Netherlands Clay Cothren

Burlew United States of America Jill Cherry-Bukowiec United States of America Raul Coimbra United States of America Salomone Di Saverio Italy Samer Doughan United Kingdom Alex Escalona Chile Aristomenis K Exadaktylos Lonafarnib in vivo Switzerland Alessandro Fancellu Italy Tatsuma Fukuda Japan Ralf Herbert Gahr Germany Athanasios Giannoukas Greece Sanjay Gupta India John Holcomb United States of America Rao Ivatury United States of America Nobuyasu Kano Japan Dimos Karangelis United Kingdom Kenji Kawamukai Italy Michael Kelly Australia Fernando Kim United States of America Yoram Kluger Israel Janusz Kowalewski Poland Rifat Latifi United States of America Philipp Lenzlinger Switzerland Celestino Pio Lombardi Italy Sheikh Muzamil India Takashi Nagata Japan Mehdi Ouaissi France Giorgio Rossi Italy Sandeep Sainathan United States of America Boris Sakakushev Bulgaria Özge Senyaman Germany R. Stephen Smith United States of America Korhan Taviloglu Turkey Tomislav Trupkovic Germany Gregorio Tugnoli Italy George Velmahos United States of America Suemoy Wallace United States of America Imtiaz Wani India”
“Introduction Acute mesenteric ischemia (AMI) is a GKT137831 lethal disease with high mortality rates ranging from 24 to 94%. This is attributed to delayed diagnosis, ineffective treatment regimens and moribund patients [1–3].

Comments are closed.